CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 71 target
Drug / intervention
maintained antipsychotic treatment vs. stepwise drug discontinuationother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00159120
NCT00159120Phase 4Completed

Maintenance Treatment vs. Stepwise Drug Discontinuation After One Year of Maintenance Treatment in First-Episode Schizophrenia

Heinrich-Heine University, Duesseldorf·interventional·Posted Sep 12, 2005·Updated Jan 30, 2008

In Brief

A Phase 4 clinical trial evaluating maintained antipsychotic treatment vs. stepwise drug discontinuation for Schizophrenia and Psychoses. Completed, enrolled 71 participants across 1 site.

Detailed Summary

After one year neuroleptic maintenance treatment in patients with first episode schizophrenia, neuroleptic treatment will be continued vs. stepwise discontinued (randomized design) over a period of 1 year. Under both conditions prodrome based early intervention take place.

Study Details

Timeline

Phase 4CompletedFinished
20022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedSep 12, 2005
Enrollment StartNov 1, 2001
Primary CompletionJun 1, 2006
TodayJul 2, 2026
Enrollment to primary: 4.6 yearsPosted 20.8 years ago

Interventions

maintained antipsychotic treatment vs. stepwise drug discontinuationother

maintained antipsychotic treatment (in low dose) vs. stepwise drug discontinuation; both supplemented by prodrome-based early intervention; 1 year